A method for improving the survival rate of a patient exposed to an endotoxin, {HEAD ~ the method} comprising the step of administering tumor cytotoxic factor II intravenously, intramuscularly or subcutaneously to said patient in an amount effective to improve {TAIL ~ the survival rate} of said patient, wherein the TCF II is administered before or after said patient is exposed to an endotoxin 
A method for improving the survival rate of a patient exposed to an endotoxin , { HEAD ~ the method } comprising the step of administering tumor cytotoxic factor II intravenously , intramuscularly or subcutaneously to said patient in an amount effective to improve { TAIL ~ the survival rate } of said patient , wherein the TCF II is administered before or after said patient is exposed to an endotoxin
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH